Werbung
Werbung

ASTH

ASTH logo

Astrana Health Inc. Common Stock

28.41
USD
Gesponsert
+0.20
+0.69%
09. Jan., 15:59 UTC -5
Geschlossen
exchange

Nach-Markt

28.43

+0.01
+0.04%

ASTH Ergebnisberichte

Positives Überraschungsverhältnis

ASTH übertreffen die 18 der letzten 30Schätzungen.

60%

Nächster Bericht

Datum des nächsten Berichts
25. Feb. 2026
Estimate for Q4 25 (Revenue/ EPS)
$949.07M
/
$0.10
Implizierte Änderung von Q3 25 (Revenue/ EPS)
-0.73%
/
+900.00%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
+42.67%
/
-166.67%

Astrana Health Inc. Common Stock earnings per share and revenue

On 06. Nov. 2025, ASTH reported earnings of 0.01 USD per share (EPS) for Q3 25, missing the estimate of 0.45 USD, resulting in a -97.78% surprise. Revenue reached 956.05 million, compared to an expected 971.84 million, with a -1.63% difference. The market reacted with a -23.46% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 12 analysts forecast an EPS of 0.10 USD, with revenue projected to reach 949.07 million USD, implying an increase of 900.00% EPS, and decrease of -0.73% in Revenue from the last quarter.
FAQ
For Q3 2025, Astrana Health Inc. Common Stock reported EPS of $0.01, missing estimates by -97.78%, and revenue of $956.05M, -1.63% below expectations.
The stock price moved down -23.46%, changed from $33.36 before the earnings release to $25.54 the day after.
The next earning report is scheduled for 25. Feb. 2026.
Based on 12 analysts, Astrana Health Inc. Common Stock is expected to report EPS of $0.10 and revenue of $949.07M for Q4 2025.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung